FDA Updates Nasal Decongestant Inhaler/Vapor Inhaler Exclusion from Controlled Substances Act

Summary

The Drug Enforcement Administration has updated the table of Excluded Nonnarcotic Products to reflect a name change for the Nasal Decongestant Inhaler/Vapor Inhaler, a nonnarcotic over-the-counter drug product, to Aphena Pharma Solutions--New York, LLC, as part of a final rule adopted from the 2015 interim final rule.